PEER-reviewed Publications 2020

1 Uptake and Discontinuation of Integrase Inhibitors (INSTIs) in a Large Cohort Setting. Greenberg L, Ryom L, Wandeler G, Grabmeier-Pfistershammer K, Öllinger A, Neesgaard B, Stephan C, Calmy A, Rauch A, Castagna A, Spagnuolo V, Johnson M, Stingone C, Mussini C, De Wit S, Necsoi C, Campins AA, Pradier C, Stecher M, Wasmuth JC, Monforte AD, Law M, Puhr R, Chkhartishvilli N, Tsertsvadze T, Garges H, Thorpe D, Lundgren JD, Peters L, Bansi-Matharu L, Mocroft A; RESPOND Study Group.
J Acquir Immune Defic Syndr. 2020;83(3):240-250. Abstract

2 Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment. Mocroft A, Lundgren J, Gerstoft J, Rasmussen LD, Bhagani S, Aho I, Pradier C, Bogner JR, Mussini C, Uberti Foppa C, Maltez F, Laguno M, Wandeler G, Falconer K, Trofimova T, Borodulina E, Jevtovic D, Bakowska E, Kase K, Kyselyova G, Haubrich R, Rockstroh JK, Peters L; EuroSIDA Study.
Clin Infect Dis. 2020;70(10):2131-2140. Abstract

3 Development and validation of a cycle-specific risk score for febrile neutropenia during chemotherapy cycles 2-6 in patients with solid cancers: The CSR FENCE score. Aagaard T, Reekie J, Roen A, Daugaard G, Specht L, Sengeløv H, Mocroft A, Lundgren J, Helleberg M.
Int J Cancer. 2020;146(2):321-328. Abstract

4 Mortality and admission to intensive care units after febrile neutropenia in patients with cancer. Aagaard, T., Reekie, J., Jørgensen, M., Roen, A., Daugaard, G., Specht, L., Sengeløv, H., Mocroft, A., Lundgren, J., Helleberg, M.
Cancer Medicine, 2020;9(9):3033-3042. Abstract

5 Use of inhaled corticosteroids and the risk of developing type 2 diabetes in patients with chronic obstructive pulmonary disease. Saeed, M. I., Eklöf, J., Achir, I., Sivapalan, P., Meteran, H., Løkke, A., Biering-Sørensen, T., Knop, F. K., Jensen, J. S.
Diabetes Obes Metab. 2020. Abstract

6 Lymphopenia and neutropenia are associated with subsequent incident proteinuria in Danish patients with systemic lupus erythematosus . Tanha, N., Hansen, R. B., Yang, J., Lange, T., Nielsen, C. T., Helleberg, M., Kamper, A., Faurschou, M., Jacobsen, S.
Scand J Rheumatol. 2020;49(2):122-130. Abstract

7 Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines. Phillips, A. N., Bansi-Matharu, L., Venter, F., Havlir, D., Pozniak, A., Kuritzkes, D. R., Wensing, A., Lundgren, J. D., Pillay, D., Mellors, J., Cambiano, V., Jahn, A., Apollo, T., Mugurungi, O., Ripin, D., Da Silva, J., Raizes, E., Ford, N., Siberry, G. K., Gupta, R. K., Barnabas, R., Revill, P., Cohn, J., Calmy, A., Bertagnolio, S.
Lancet HIV. 2020;7(3):e193-e200. Abstract

8 Pericardial adipose tissue volume is independently associated with HIV status and prior use of stavudine, didanosine or indinavir. Knudsen, A. D., Krebs-Demmer, L., Bjørge, N. I. D., Elming, M. B., Gelpi, M., Sigvardsen, P. E., Lebech, A., Fuchs, A., KüHL, J. T., Køber, L., Lundgren, J., Nordestgaard, B. G., Kofoed, K. F., Nielsen, S. D.
The Journal of infectious diseases. 2020. Abstract

9 Remdesivir for the Treatment of Covid-19 - Preliminary Report. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh MD, Ruiz-Palacios GM, Benfield T, Fätkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC; ACTT-1 Study Group Members.
N Engl J Med. 2020:NEJMoa2007764. Abstract

10 Prevalence and Risk Factors of Moderate to Severe Hepatic Steatosis in HIV Infection: The Copenhagen Co-Morbidity Liver Study. Kirkegaard-Klitbo DM, Fuchs A, Stender S, Sigvardsen PE, Kühl JT, Kofoed KF, Køber L, Nordestgaard BG, Bendtsen F, Mocroft A, Lundgren J, Nielsen SD, Benfield T.
Infect Dis. 2020:jiaa246. Abstract

11 Cutaneous leishmaniasis with secondary mucosal disease in a traveller due to Leishmania (Viannia) braziliensis. Crone, C. G., Helleberg, M.
Journal of Travel Medicine. 2020. Abstract

12 Prevalence of and Risk Factors for Low Bone Mineral Density Assessed by Quantitative Computed Tomography in People Living With HIV and Uninfected Controls . Thomsen, M. T., Wiegandt, Y. L., Gelpi, M., Knudsen, A. D., Fuchs, A., Sigvardsen, P. E., Kühl, J. T., Nordestgaard, B., Køber, L., Lundgren, J., Hansen, A. E., Kofoed, K. F., Jensen, J. B., Nielsen, S. D.
J Acquir Immune Defic Syndr. 2020;83(2):165-172. Abstract

13 Risk factors during pregnancy and birth-related complications in HIV-positive versus HIV-negative women in Denmark, 2002-2014. Ørbaek, M., Thorsteinsson, K., Moseholm Larsen, E., Katzenstein, T. L., Storgaard, M., Johansen, I. S., Pedersen, G., Bach, D., Helleberg, M., Weis, N., Lebech, A.
HIV Med. 2020;21(2):84-95. Abstract

14 International Society of Cardiovascular Infectious Diseases Guidelines for the Diagnosis, Treatment and Prevention of Disseminated Mycobacterium chimaera Infection Following Cardiac Surgery with Cardiopulmonary Bypass. Hasse, B., Hannan, M., Keller, P. M., Maurer, F. P., Sommerstein, R., Mertz, D., Wagner, D., Fernández-Hidalgo, N., Nomura, J., Manfrin, V., Bettex, D., Conte, A. H., Durante-Mangoni, E., Hing-Cheung Tang, T., Stuart, R. L., Lundgren, J., Gordon, S., Jarashow, M. C., Schreiber, P. W., Niemann, S., Kohl, T. A., Daley, C., Stewardson, A. J., Whitener, C. J., Perkins, K., Plachouras, D., Lamagni, T., Chand, M., Freiberger, T., Zweifel, S., Sander, P., Schulthess, B., Scriven, J., Sax, H., van Ingen, J., Mestres, C. A., Diekema, D., Brown-Elliott, B. A., Wallace, R. J., Baddour, L. M., Miro, J. M., Hoen, B., M. chimaera ISCVID investigators.
J Hosp Infect. 2020;104(2):214-235. Abstract

15 Plasma Albumin and Incident Cardiovascular Disease: Results From the CGPS and an Updated Meta-Analysis. Ronit, A., Kirkegaard-Klitbo, D. M., Dohlmann, T. L., Lundgren, J., Sabin, C. A., Phillips, A. N., Nordestgaard, B. G., Afzal, S.
Arterioscler Thromb Vasc Biol. 2020;40(2):473-482. Abstract

16 Interstitial lung abnormalities in people with HIV infection and uninfected controls. Ronit, A., Benfield, T., Lundgren, J., Vestbo, J., Afzal, S., Nordestgaard, B. G., Kühl, J. T., Kofoed, K. F., Nielsen, S. D., Kristensen, T.
J Infect Dis. 20201; 221(12):1973-1977. Abstract

17 Machine learning can identify newly diagnosed patients with CLL at high risk of infection. Agius, R., Brieghel, C., Andersen, M. A., Pearson, A. T., Ledergerber, B., Cozzi-Lepri, A., Louzoun, Y., Andersen, C. L., Bergstedt, J., von Stemann, J. H., Jørgensen, M., Tang, M. E., Fontes, M., Bahlo, J., Herling, C. D., Hallek, M., Lundgren, J., MacPherson, C. R., Larsen, J., Niemann, C. U.
Nat Commun. 2020;11(1):363. Abstract

18 Fraction of exhaled nitric oxide levels are elevated in people living with HIV compared to uninfected controls suggesting increased eosinophilic airway inflammation. Thudium, R. F., Hughes, N. L. P., Afzal, S., Çolak, Y., Gelpi, M., Knudsen, A. D., Kirkegaard-Klitbo, D. M., Borges, Á. H., Gerstoft, J., Nordestgaard, B. G., Vestbo, J., Lundgren, J., Ronit, A., Nielsen, S. D.
Clin Infect Dis. 2020. Abstract

19 Impact of Hiv-Related Gut Microbiota Alterations on Metabolic Comorbidities. Gelpi, M., Vestad, B., Hansen, S. H., Holm, K., Drivsholm, N., Goetz, A., Kirkby, N. S., Lindegaard, B., Lebech, A., Hoel, H., Michelsen, A. E., Ueland, T., Gerstoft, J., Lundgren, J., Hov, J. R., Nielsen, S. D., Trøseid, M.
Clin Infect Dis. 2020. Abstract

20 Abdominal adipose tissue is associated with alterations in tryptophan-kynurenine metabolism and markers of systemic inflammation in people with HIV. Gelpi, M., Ueland, P. M., Trøseid, M., Mocroft, A., Lebech, A., Ullum, H., Midttun, Ø., Lundgren, J., Nielsen, S. D., Copenhagen Comorbidity in HIV Infection (COCOMO) Study.
J Infect Dis. 2020;221(3):419-427. Abstract

21 Evaluation of an electronic, patient-focused management system aimed at preventing cytomegalovirus disease following solid organ transplantation. Ekenberg, C., da Cunha-Bang, C., Lodding, I. P., Sørensen, S. S., Sengeløv, H., Perch, M., Rasmussen, A., Gustafsson, F., Wareham, N. E., Kirkby, N., Kjaer, J., Helleberg, M., Reekie, J., Lundgren, J. D.
Transpl Infect Dis. 2020. Abstract

22 Physiological abnormalities in patients admitted with acute exacerbation of COPD: an observational study with continuous monitoring. Elvekjaer, M., Aasvang, E. K., Olsen, R. M., Sørensen, H. B. D., Porsbjerg, C. M., Jensen, J., Haahr-Raunkjær, C., Meyhoff, C. S., WARD-Project Group.
J Clin Monit Comput. 2019. [Online ahead of print]. Abstract

23 Poor concordance between liver stiffness and non-invasive fibrosis scores in HIV infection without viral hepatitis. Kirkegaard-Klitbo, D. M., Bendtsen, F., Lundgren, J., Nielsen, S. D., Benfield, T., COCOMO study group.
Clin Gastroenterol Hepatol. 2019. [Online ahead of print]. Abstract

24 Tuberculosis among Patients Undergoing Solid Organ Transplantation or Dialysis in a Low-Endemic Country, 2004-2017. Helleberg, M., Cho, D., Ekenberg, C., Sørensen, S., Rix, M., Gustafsson, F., Rasmussen, A., Perch, M., Andersen, P. H. S., Lundgren, J. D., Andersen, A. B.
Tuberc Res Treat. 2020. Abstract

25 Variant in ERAP1 promoter region is associated with low expression in a patient with a Behçet-like MHC-I-opathy. Dimopoulou, C., Lundgren, J. D., Sundal, J., Ullum, H., Aukrust, P., Nielsen, F. C., Marvig, R. L.
J Hum Genet. 2020;65(3):325-335. Abstract

26 Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral‐naïve persons starting treatment. Mocroft A, Neesgard B, Zangerle R, Rieger A, Castagna A, Spagnuolo V, Antinori A, Lampe F C, Youle M, Vehreschild J J, Mussini C, Borghi V, Begovac J, Duvivier C, Gunthard H F, Rauch A, Tiraboschi J, Chkhartishvili N, Bolokadze N, Wit F, Wasmuth J C, De Wit S, Necsoi C, Pradier C, Svedhem V, Stephan C, Petoumenos K, Garges H, Rogatto F, Peters L, Ryom L; RESPOND study group.
HIV Med. 2020 Abstract

27 Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons. A Mocroft, L Ryom, C Oprea, Q Li, A Rauch, C Boesecke, V Uzdaviniene, D Sedlacek, JM. Llibre, K Lacombe,  LN. Nielsen,  Florence, I Aho, N Chkhartishvili, J Szlavik, G Dragovic, C Leen, H Sambatakou, T Staub, M Laguno, H Elinav, J Tomazic, L Peters, for the EuroSIDA study group
AIDS. 2020;34(10):1485-1495. Abstract

28 How to RESPOND to Modern Challenges for People Living with HIV: A Profile for a New Cohort Consortium. B Neesgaard *, A Mocroft, L Greenberg, JF Larsen, G Wandeler, R Zangerle, H Günthard, C Smith, S De Wit, C Mussini, A Castagna, a D'Arminio Monforte, JJ Vehreschild, JC Wasmuth, C Pradier, N Chkhartishvili, F W.N.M. Wit, M Law, A Sönnerborg, A Bruguera, C Stephan, V Vannappagari, R Haubrich, O Kirk, D Podlekareva, J Kowalska, D Raben, J Rockstroh, L Peters, R Parades, K Grabmeier-Pfistershammer, A Scherrer, M Johnson, C Necsoi, V Borghi, C Muccini, T Tserstvadze, K Petoumenos, A Volny-Anne, J Lundgren, L Ryom, for the RESPOND study group
Microorganisms. 2020;8(8):E1164. Abstract

29 Epidemiology of hepatitis E virus infection in a cohort of 4023 immunocompromised patients. Harritshøj, L. H., Hother, C. E., Sengeløv, H., Daugaard, G., Sørensen, S. S., Jacobsen, S., Perch, M., Holm, D. K., Sækmose, S. G., Aagaard, B., Erikstrup, C., Hogema, B. M., Lundgren, J. D. & Ullum, H
Int J Infect Dis. 2020;91:188-195. Abstract

30 GenAPI: a tool for gene absence-presence identification in fragmented bacterial genome sequences. Migle Gabrielaite, Rasmus L Marvig
BMC Bioinformatics. 2020;21(1):320. Abstract

31 Identifying cross-disease components of genetic risk across hospital data in the UK Biobank. Cortes A, Albers PK, Dendrou CA, Fugger L, McVean G
Nat Genet. 2020;52(1):126-134. Abstract

32 Invasive aspergillosis in patients with severe COVID-19 pneumonia. Helleberg M, Steensen M, Arendrup MC.
Clin Microbiol Infect. 2020;S1198-743X(20)30474-2, Abstract

33 Monitoring CD8a+ T Cell Responses to Radiotherapy and CTLA-4 Blockade Using [64Cu]NOTA-CD8a PET Imaging. Kristensen LK, Christensen C, Alfsen MZ, Cold S, Nielsen CH, Kjaer A.
NMol Imaging Biol. 2020;22(4):1021-1030. Abstract

34 Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy. Helleberg M, Niemann CU, Moestrup KS, Kirk O, Lebech AM, Lane C, Lundgren J.
J Infect Dis. 2020;222(7):1103-1107. Abstract

35 Primary ciliary dyskinesia patients have the same P. aeruginosa clone in sinuses and lungs. Arndal E, Johansen HK, Haagensen JAJ, Bartell JA, Marvig RL, Alanin M, Aanæs K, Høiby N, Nielsen KG, Backer V, von Buchwald C.
Eur Respir J. 2020;55(1):1901472. Abstract

36 Rezafungin In Vitro Activity against Contemporary Nordic Clinical Candida Isolates and Candida auris Determined by the EUCAST Reference Method. Helleberg M, Jørgensen KM, Hare RK, Datcu R, Chowdhary A, Arendrup MC.
Antimicrob Agents Chemother. 2020;64(4):e02438-19. Abstract

37 Role of inflammatory biomarkers in the prevalence and incidence of hypertension among HIV-positive participants in the START trial. Ghazi L, Baker JV, Sharma S, Jain MK, Palfreeman A, Necsoi C, Murray DD, Neaton JD, Drawz PE for the INSIGHT START study group. 
Am J Hypertens 2020; 33(1):43–52. Abstract

38 Influence of Hepatitis C coinfection and treatment on risk of diabetes mellitus in HIV-positive persons A Mocroft, JD Lundgren, J Rockstroh, I Aho, G Wandeler, L Nielsen, S Edwards, J Viard, K Lacombe, G Fätkenheuer, G Guaraldi, M Laguno, J Llibre, H Elinav, L Flamholc, M Gisinger, D Paduta, I Khromova, D Jilich, B Rozplochowski, C Oprea, L Peters on behalf of the EuroSIDA study
Open Forum Infectious Diseases 2020 Abstract

39 Estimating the burden of HIV late presentation and its attributable morbidity and mortality across Europe 2010-2016. Kamilla Laut, M.D, Ph.D; Andrea Antinori; Barbara Bartmeyer; Marek Beniowski; Fabrice Bonnet; Johanna Brännström; Jordi Casabona; Antonella Castagna; Genevieve Chene; Dominique Costagliola; Antonella d'Arminio Monforte; Julia del Amo; Stephane De Wit; Gerd Faetkenheuer; Hansjakob Furrer; Jacek Gasiorowski; Corinne Jadand; Ole Kirk; Mario K Lazanas; Ignacio Suarez-Lozano; Jens Lundgren; Julia Mikhalik; Amanda Mocroft; Santiago Moreno; Cristina Mussini; Niels Obel; Dzimitry Paduta; Dorthe Raben; Peter Reiss; Andrew Riordan; Caroline A Sabin; Jelena Smidt; Carlo Torti; Tatiana Trofimova; Anna Vassilenko; Marta Vasylyev; Josiane Warszawski; Linda Wittkop; Alexei Yakovlev; Robert Zangerle.
BMC Infect Dis. 2020 7;20(1):728. Abstract

40 What do the changing patterns of comorbidity burden in people living with HIV mean for long‐term management? Perspectives from European HIV cohorts A d'Arminio Monforte, F Bonnet, HC Bucher, V Pourcher, N Pantazis, A Pelchen‐Matthews, G Touloumi , E Wolf
HIV Med. 2020. Abstract

41 Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients. Ilett EE, Jørgensen M, Noguera-Julian M, Nørgaard JC, Daugaard G, Helleberg M, Paredes R, Murray DD, Lundgren J, MacPherson C, Reekie J, Sengeløv H. 
Blood Adv. 2020;4(22):5797-5809. Abstract

42 A new health care index predicts short term mortality for TB and HIV co-infected people. Roen AO, Podlekareva D, Miller RF, Mocroft A, Panteleev A, Skrahina A, Miro JM, Cayla JA, Tetradov S, Derisova E, Furrer H, Losso MH, Vassilenko A, Girardi E, Lundgren JD, Post FA, Kirk O.
Int J Tuberc Lung Dis. 2020;24(9):956-962. Abstract

43 Withholding primary PcP prophylaxis in virologically suppressed HIV patients: An emulation of a pragmatic trial in COHERE. Atkinson A, Zwahlen M, Barger D, d'Arminio Monforte A, De Wit S, Ghosn J, Girardi E, Svedhem-Johansson V, Morlat P, Mussini C, Noguera-Julian A, Stephan C, Touloumi G, Kirk O, Mocroft A, Reiss P, Miro JM, Carpenter JR, Furrer H; Opportunistic Infections Project Working Group of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.
Clin Infect Dis. 2020:ciaa615. Abstract

44 Healthcare delivery for HIV-positive people with tuberculosis in Europe. Bentzon AK, Panteleev A, Mitsura V, Borodulina E, Skrahina A, Denisova E, Tetradov S, Podlasin R, Riekstina V, Kancauskiene Z, Paduto D, Mocroft A, Trofimova T, Miller R, Post F, Grezesczuk A, Lundgren JD, Inglot M, Podlekareva D, Bolokadze N, Kirk O; TB:HIV Study Group.
HIV Med. 2020. Epub ahead of print. Abstract

45 The impact of immunosuppression on chronic kidney disease in people living with HIV; the D:A:D study. Ryom L, Lundgren JD, Reiss P, Ross M, Kirk O, Fux CA, Morlat P, Fontas E, Smith C, De Wit S, d'Arminio Monforte A, El Sadr W, Hatleberg C, Phillips A, Sabin C, Law M, Mocroft A; D:A:D Study Group.
J Infect Dis. 2020:jiaa396. Epub ahead of print. Abstract

46 2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0. Ryom L, Cotter A, De Miguel R, Béguelin C, Podlekareva D, Arribas JR, Marzolini C, Mallon P, Rauch A, Kirk O, Molina JM, Guaraldi G, Winston A, Bhagani S, Cinque P, Kowalska JD, Collins S, Battegay M; EACS Governing Board.
HIV Med. 2020(10):617-624. Abstract

47 The interrelationship of smoking, CD4+ cell count, viral load and cancer in persons living with HIV. RESPOND Study Group, Ryom, L., Peters, L. & Lundgren, J. D.
AIDS. 2020;35(5):747-757. Abstract

48 Clinical outcomes of two-drug regimens vs. three-drug regimens in antiretroviral treatment-experienced people living with HIV. Greenberg L, Ryom L, Neesgaard B, Wandeler G, Staub T, Gisinger M, Skoll M, Günthard HF, Scherrer A, Mussini C, Smith C, Johnson M, De Wit S, Necsoi C, Pradier C, Wit F, Lehmann C, d'Arminio Monforte A, Miró JM, Castagna A, Spagnuolo V, Sönnerborg A, Law M, Hutchinson J, Chkhartishvili N, Bolokadze N, Wasmuth JC, Stephan C, Vannappagari V, Rogatto F, Llibre JM, Duvivier C, Hoy J, Bloch M, Bucher HC, Calmy A, Volny Anne A, Pelchen-Matthews A, Lundgren JD, Peters L, Bansi-Matharu L, Mocroft A; RESPOND study group.
Clin Infect Dis. 2020. Abstract

49 Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium.  
Bastian Neesgaard, Amanda Mocroft, Robert Zangerle, Ferdinand Wit, Fiona Lampe, Huldrych F Günthard, Coca Necsoi, Matthew Law, Cristina Mussini, Antonella Castagna, Antonella d'Arminio Monforte, Christian Pradier, Nikoloz Chkhartisvilli, Juliana Reyes-Uruena, Jörg Janne Vehreschild, Jan-Christian Wasmuth, Anders Sönnerborg, Christoph Stephan, Lauren Greenberg, Josep M Llibre, Alain Volny-Anne, Lars Peters, Annegret Pelchen-Matthews, Vani Vannappagari, Joel Gallant, Armin Rieger, Mike Youle, Dominique Braun, Stephane De Wit, Kathy Petoumenos, Vanni Borghi, Vincenzo Spagnuolo, Tengiz Tsertsvadze, Jens Lundgren, Lene Ryom, RESPOND study group 
PLoS One . 2020;15(12):e0243625.  Abstract

50 Effectiveness and safety of IFN-free DAA HCV therapy in HIV/HCV co-infected persons: Results from a pan-European study. Amele S, Peters L, Rodger A, Lundgren J, Rockstroh J, Matulionyte R, Leen C, Jabłonowska E, Østergaard L, Bhagani S, Sarcletti M, Clarke A, Falconer K, Wandeler G, Domingo P, Maltez F, Zaccarelli M, Chkhartisvili N, Szlavik J, Stephan C, Fonquernie L, Aho I, Mocroft A.
J Acquir Immune Defic Syndr. 2020. Epub ahead of print. Abstract

51 Effect of changes in body mass index on the risk of cardiovascular disease and diabetes mellitus in HIV-positive individuals: results from the D: A: D study. Petoumenos K, Kuwanda L, Ryom L, Mocroft A, Reiss P, De Wit S, Pradier C, Phillips A, Hatleberg CI, d'Arminio Monforte A, Weber R, Sabin CA, Lundgren J, Law MG; D:A:D Study group.
J Acquir Immune Defic Syndr. 2020. Abstract

52 Design and implementation of the multi-arm, multi-stage Therapeutics for Inpatients with COVID-19 (TICO) platform master protocol: An Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative. Murray DD, Babiker AG, Baker JV, Barkauskas CE, Brown SM, Chang C, Davey VJ, Gelijns AC, Ginde AA, Grund B, Higgs E, Hudson F, Kan VL, Lane HC, Murray TA, Paredes R, Parmar MKB, Pett S, Phillips AN, Polizzotto MN, Reilly C, Sandkovsky U, Sharma S, Teitelbaum M, Thompson BT, Young BE, Neaton JD, Lundgren JD.
medRxiv [Preprint]. 2020:2020.11.08.20227876. Abstract

53 A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19. ACTIV-3/TICO LY-CoV555 Study Group, Lundgren JD, Grund B, Barkauskas CE, Holland TL, Gottlieb RL, Sandkovsky U, Brown SM, Knowlton KU, Self WH, Files DC, Jain MK, Benfield T, Bowdish ME, Leshnower BG, Baker JV, Jensen JU, Gardner EM, Ginde AA, Harris ES, Johansen IS, Markowitz N, Matthay MA, Østergaard L, Chang CC, Davey VJ, Goodman A, Higgs ES, Murray DD, Murray TA, Paredes R, Parmar MKB, Phillips AN, Reilly C, Sharma S, Dewar RL, Teitelbaum M, Wentworth D, Cao H, Klekotka P, Babiker AG, Gelijns AC, Kan VL, Polizzotto MN, Thompson BT, Lane HC, Neaton JD.
N Engl J Med. 2020. Epub ahead of print. Abstract

54 Remdesivir for the Treatment of Covid-19 - Final Report. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh MD, Ruiz-Palacios GM, Benfield T, Fätkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC; ACTT-1 Study Group Members.
N Engl J Med. 2020;383(19):1813-1826. Abstract

55 Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. Kalil AC, Patterson TF, Mehta AK, Tomashek KM, Wolfe CR, Ghazaryan V, Marconi VC, Ruiz-Palacios GM, Hsieh L, Kline S, Tapson V, Iovine NM, Jain MK, Sweeney DA, El Sahly HM, Branche AR, Regalado Pineda J, Lye DC, Sandkovsky U, Luetkemeyer AF, Cohen SH, Finberg RW, Jackson PEH, Taiwo B, Paules CI, Arguinchona H, Goepfert P, Ahuja N, Frank M, Oh MD, Kim ES, Tan SY, Mularski RA, Nielsen H, Ponce PO, Taylor BS, Larson L, Rouphael NG, Saklawi Y, Cantos VD, Ko ER, Engemann JJ, Amin AN, Watanabe M, Billings J, Elie MC, Davey RT, Burgess TH, Ferreira J, Green M, Makowski M, Cardoso A, de Bono S, Bonnett T, Proschan M, Deye GA, Dempsey W, Nayak SU, Dodd LE, Beigel JH.
N Engl J Med. 2020. Epub ahead of print. Abstract

56 Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high incidence of cancer prone syndromes. Byrjalsen A, Hansen TVO, Stoltze UK, Mehrjouy MM, Barnkob NM, Hjalgrim LL, Mathiasen R, Lautrup CK, Gregersen PA, Hasle H, Wehner PS, Tuckuviene R, Sackett PW, Laspiur AO, Rossing M, Marvig RL, Tommerup N, Olsen TE, Scheie D, Gupta R, Gerdes AM, Schmiegelow K, Wadt K.
PLoS Genet. 2020 Dec 17;16(12):e1009231. Abstract

57 Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits. Mathioudakis AG, Janssens W, Sivapalan P, Singanayagam A, Dransfield MT, Jensen JS, Vestbo J.
Thorax. 2020;75(6):520-527. Abstract

58 Case Report: Hyper IgM Syndrome Identified by Whole Genome Sequencing in a Young Syrian Man Presenting With Atypical, Severe and Recurrent Mucosal Leishmaniasis. Drabe CH, Marvig RL, Borgwardt L, Lundgren JD, Maquart HVH, Katzenstein TL, Helleberg M.
Front Immunol. 2020;11:567856. Abstract

59 Children Exposed or Unexposed to Human Immunodeficiency Virus: Weight, Height, and Body Mass Index During the First 5 Years of Life-A Danish Nationwide Cohort. Moseholm E, Helleberg M, Sandholdt H, Katzenstein TL, Storgaard M, Pedersen G, Johansen IS, Weis N.
Clin Infect Dis. 2020;70(10):2168-2177. Abstract

60 Compassionate Use of Remdesivir in Covid-19. Fätkenheuer G, Lundgren J.
N Engl J Med. 2020;382(25):e101. Abstract

61 Contribution of Genetic Background and Data Collection on Adverse Events of Anti-human Immunodeficiency Virus (HIV) Drugs (D:A:D) Clinical Risk Score to Chronic Kidney Disease in Swiss HIV-infected Persons With Normal Baseline Estimated Glomerular Filtration Rate. Dietrich LG, Barceló C, Thorball CW, Ryom L, Burkhalter F, Hasse B, Furrer H, Weisser M, Steffen A, Bernasconi E, Cavassini M, de Seigneux S, Csajka C, Fellay J, Ledergerber B, Tarr PE.
Clin Infect Dis. 2020;70(5):890-897. Abstract

62 Correction: Epidemiology of bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal nation-wide cohort study. Andersen MA, Moser CE, Lundgren J, Niemann CU.
Leukemia. 2020;34(10):2817-2818. Abstract

63 Myocardial Impairment and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19: The ECHOVID-19 Study. Skaarup KG, Lassen MCH, Lind JN, Alhakak AS, Sengeløv M, Nielsen AB, Espersen C, Hauser R, Schöps LB, Holt E, Johansen ND, Modin D, Sharma S, Graff C, Bundgaard H, Hassager C, Jabbari R, Lebech AM, Kirk O, Bødtger U, Lindholm MG, Joseph G, Wiese L, Schiødt FV, Kristiansen OP, Walsted ES, Nielsen OW, Madsen BL, Tønder N, Benfield TL, Jeschke KN, Ulrik CS, Knop FK, Pallisgaard J, Lamberts M, Sivapalan P, Gislason G, Solomon SD, Iversen K, Jensen JUS, Schou M, Biering-Sørensen T.
JACC Cardiovasc Imaging. 2020;13(11):2474-2476. Abstract

64 Recently acquired and early chronic hepatitis C in MSM: Recommendations from the European treatment network for HIV, hepatitis and global infectious diseases consensus panel. Boesecke C, Boyd A, Rauch A, Lacombe K, Rodger A, Pharris A, Pozniak A, Rijnders B, Smit C, Hoornenborg E, Wedemeyer H, Schinkel J, Nerlander L, Duffell E, Noori T, Berenguer J, Peters L, Cotte L, Salazar-Vizcaya L, Puoti M, Parczewski M, Martin M, Ingiliz P, Zandkuijl P, Dressler S, Naggie S, van de Laar T, Reiberger T, Matthews G, Bhagani S, Prins M, Rockstroh JK.
AIDS. 2020;34(12):1699-1711. Abstract

65 Remdesivir til behandling af COVID-19-pneumoni. Benfiels T, Jensen TØ, Johansen IS, Nielsen H, Wiese L, Østergaard L, Lundgren J.
Ugeskr Laeger. 2020;182(24):V205031. Danish. Abstract

66 Renal function in Ethiopian HIV-positive adults on antiretroviral treatment with and without tenofovir. Yilma D, Abdissa A, Kæstel P, Tesfaye M, Olsen MF, Girma T, Ritz C, Friis H, Andersen ÅB, Kirk O.
BMC Infect Dis. 2020;20(1):582 Abstract

67 Richter's transformation in patients with chronic lymphocytic leukaemia: a Nationwide Epidemiological Study. Ben-Dali Y, Hleuhel MH, da Cunha-Bang C, Brieghel C, Poulsen CB, Clasen-Linde E, Bentzen HHN, Frederiksen H, Christiansen I, Nielsen LH, Enggaard L, Helleberg M, Clausen M, Frederiksen M, Pedersen RS, Niemann CU, Andersen MA.
Leuk Lymphoma. 2020;61(6):1435-1444. Abstract

68 The clinical spectrum of tularemia-Two cases. Ørbæk M, Lebech AM, Helleberg M.
IDCases. 2020;21:e00890. Abstract

69 The EuroSIDA study: 25 years of scientific achievements. Laut K, Kirk O, Rockstroh J, Phillips A, Ledergerber B, Gatell J, Gazzard B, Horban A, Karpov I, Losso M, d'Arminio Monforte A, Pedersen C, Ristola M, Reiss P, Scherrer AU, de Wit S, Aho I, Rasmussen LD, Svedhem V, Wandeler G, Pradier C, Chkhartishvili N, Matulionyte R, Oprea C, Kowalska JD, Begovac J, Miró JM, Guaraldi G, Paredes R, Raben D, Podlekareva D, Peters L, Lundgren JD, Mocroft A.
HIV Med. 2020;21(2):71-83. Abstract

70 How are rapid diagnostic tests for infectious diseases used in clinical practice: a global survey by the International Society of Antimicrobial Chemotherapy (ISAC). Poole S, Townsend J, Wertheim H, Kidd SP, Welte T, Schuetz P, Luyt CE, Beishuizen A, Jensen JS, Del Castillo JG, Plebani M, Saeed K.
Eur J Clin Microbiol Infect Dis. 2020; Epub ahead of print. Abstract

71 Oxacillinase-181 Carbapenemase-Producing Klebsiella pneumoniae in Neonatal Intensive Care Unit, Ghana, 2017-2019. Labi AK, Nielsen KL, Marvig RL, Bjerrum S, Enweronu-Laryea C, Bennedbæk M, Newman MJ, Ayibor PK, Andersen LP, Kurtzhals JAL.
Emerg Infect Dis. 2020;26(9):2235-2238. Abstract

72 Cancer during HIV infection. da Silva Neto MM, Brites C, Borges ÁH.
APMIS. 2020;128(2):121-128. Abstract

73 Preoperative TruCulture® whole blood cytokine response predicts post-operative inflammation in pancreaticoduodenectomy patients-A pilot cohort study. Aasvang EK, Pitter S, Hansen CP, Storkholm JH, Krohn PS, Burgdorf SK, Von Stemann JH, Lundgren JD, Nielsen SD, Kehlet H, Ostrowski SR.
Scand J Immunol. 2020;92(3):e12930. Abstract
 
74 A call to action toward integrated testing and earlier care for viral hepatitis, HIV, STIs and TB. Raben D, Hoekstra M, Combs L, Sullivan AK, Lazarus JV, Lambert JS, Simões D, Streinu‐Cercel A, Rockstroh JK on behalf of the HepHIV Conference Organizing Committee, the EuroTEST Steering Committee, INTEGRATE Steering Committee.
HIV Medicine, 2020. Article

75 Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020. Simões, Daniel and Stengaard, Annemarie Rinder and Combs, Lauren and Raben, Dorthe and The EuroTEST COVID-19 impact assessment consortium of partners.
Eurosurveillance, Volume 25, Issue 47, 26 Nov 2020. Article

76 HIV testing strategies outside of health care settings in the European Union (EU)/European Economic Area (EEA): a systematic review to inform European Centre for Disease Prevention and Control guidance.
 Croxford S, Tavoschi L, Sullivan AK, Combs L, Raben D, Delpech V, Jakobsen SF, Amato-Gauci AJ, Desai S.
HIV Medicine, 2020. Article

77 HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA): evidence from a systematic review. Desai S, Tavoschi L, Sullivan AK, Combs L, Raben D, Delpech V, Jakobsen SF, Amato‐Gauci AJ, Croxford S
HIV Medicine, 2020. Article

78 ICT Toolkit for Integrated Prevention, Testing and Linkage to Care Across HIV, Hepatitis, STIs and Tuberculosis in Europe. Kakalou C, Cosmaro L, Dimitriadis VK, Raahauge A, Raben D, Koutkias V.
Stud Health Technol Inform. 2020;270:848-852. Abstract